Market Overview

US Stock Futures Flat Ahead Of Economic Data

Related FB
This Top Growth Fund Leans Heavily On Large-Cap Tech
Facebook Inc Shares Pulling Back After Reaching New Highs: A Pause That Refreshes?
Alibaba: The Bellwether for Upcoming IPOs (Fox Business)
Related LEN
Stocks Gain On Federal Reserve Update
Lennar Corporation Conference Call Highlights
When Rate Hikes Come, They Will Ripple Across U.S. Economy (Fox Business)

Pre-open movers

US stock futures traded mostly flat in early pre-market trade, ahead of economic data. The FHFA house price index and the S&P/Case-Shiller home price index for July will be released at 9:00 a.m. ET. The Conference Board's consumer confidence index and the Richmond Fed manufacturing index for September will be released at 10:00 a.m. ET. Futures for the Dow Jones Industrial Average gained 4 points to 15,330.00, while the Standard & Poor's 500 index futures fell 0.50 points to 1,692.20. Futures for the Nasdaq 100 index rose 5 points to 3,214.00.

A Peek Into Global Markets

European markets were mostly higher today, with the Spanish Ibex Index rising 0.32%, London's FTSE 100 index gaining 0.10% and STOXX Europe 600 Index climbing 0.10%. German DAX 30 index rose 0.11% and French CAC 40 Index surged 0.52%.

Asian markets ended mostly lower today. Japan's Nikkei Stock Average fell 0.07%, China's Shanghai Composite declined 0.61% and Australia's ASX/S&P500 dropped 0.31%. Hong Kong's Hang Seng index fell 0.82% and India's Sensex gained 0.10%.

Broker Recommendation

Analysts at Citigroup upgraded Facebook (NASDAQ: FB) from “neutral” to “buy.” The target price for Facebook has been raised from $32 to $55. Facebook's shares gained 1.63% to $47.96 in pre-market trading.

Breaking news

  • Lennar (NYSE: LEN) reported a 39% rise in its third-quarter net profit. Lennar's quarterly net profit surged to $120.7 million, or $0.54 per share, from $87.1 million, or $0.40 per share, in the year-ago period. To read the full news, click here.
  • Sanofi (NYSE: SNY) announced today new GetGoal-L sub-analysis results showing that reductions in HbA1c with Lyxumia® (lixisenatide), when added to basal insulin, were greatest in patients with type 2 diabetes who had well-controlled baseline fasting plasma glucose (FPG). To read the full news, click here.
  • ICF International (NASDAQ: ICFI) has been awarded a re-compete contract with the U.S. Environmental Protection Agency (EPA) for Homeland Security Presidential Directive 12 (HSPD-12) and Identity, Credential, and Access Management (ICAM) support. To read the full news, click here.
  • National Oilwell Varco (NYSE: NOV) announced today that its Board of Directors has authorized Company management to move forward with exploration of a plan to spin-off NOV's distribution business from the remainder of the Company, creating two stand-alone, publicly traded corporations. To read the full news, click here.

Posted-In: Citigroup US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

 

Related Articles (ICFI + FB)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters